|
Authors
|
Title
|
Source title
|
Volume
|
Issue
|
Page start
|
Page end
|
1
|
Hakimi Parizi M., Pardakhty A., Sharifi I., Farajzadeh S., Daie Parizi M.H., Sharifi H., Keyhani A.R., Mostafavi M., Bamorovat M., Ghaffari D.
|
Antileishmanial activity and immune modulatory effects of benzoxonium chloride and its entrapped forms in niosome on Leishmania tropica
|
Journal of Parasitic Diseases
|
43
|
3
|
406
|
415
|
2
|
Parizi M.H., Farajzadeh S., Sharifi I., Pardakhty A., Parizi M.H.D., Sharifi H., Salarkia E., Hassanzadeh S.
|
Antileishmanial Activity of Niosomal Combination Forms of Tioxolone along with Benzoxonium Chloride against Leishmania tropica
|
The Korean journal of parasitology
|
57
|
4
|
359
|
368
|
3
|
Mehravaran A., Rezaei Nasab M., Mirahmadi H., Sharifi I., Alijani E., Reza Nikpoor A., Akhtari J., Hojatizade M.
|
Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice
|
Iranian Journal of Basic Medical Sciences
|
22
|
8
|
922
|
931
|
4
|
Hakimi Parizi M., Sharifi I., Farajzadeh S., Pardakhty A., Parizi M., Sharifi H., Keyhani A., Mostafavi M., Bamorovat M., Khosravi A., Ghaffari D.
|
Tioxolone niosomes exert antileishmanial effects on Leishmania tropica by promoting promastigote apoptosis and immunomodulation
|
Asian Pacific Journal of Tropical Medicine
|
12
|
8
|
365
|
374
|
5
|
Mostafavi M., Sharifi I., Farajzadeh S., Khazaeli P., Sharifi H., Pourseyedi E., Kakooei S., Bamorovat M., Keyhani A., Parizi M.H., Khosravi A., Khamesipour A.
|
Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
|
Biomedicine and Pharmacotherapy
|
116
|
|
|
|
6
|
Razavinasab S.Z., Sharifi I., Aflatoonian M.R., Babaei Z., Mohammadi M.A., Salarkia E., Sharifi F., Aghaei Afshar A., Bamorovat M.
|
Expansion of urban cutaneous leishmaniasis into rural areas of southeastern Iran: Clinical, epidemiological and phylogenetic profiles explored using 7SL high resolution melting-PCR analysis
|
Transboundary and Emerging Diseases
|
66
|
4
|
1602
|
1610
|
7
|
Mostafavi M., Farajzadeh S., Sharifi I., Khazaeli P., Sharifi H.
|
Leishmanicidal effects of amphotericin B in combination with selenium loaded on niosome against Leishmania tropica
|
Journal of Parasitic Diseases
|
43
|
2
|
176
|
185
|
8
|
Tohidi F., Babaei Z., Kazemi B., Bandehpour M., Sharifi I., Rabiei M., Dezaki E.
|
Transient knockdown of Nucleoside transporter 4 gene expression as a therapeutic target in Leishmania major by antisense RNA: In vitro and in vivo studies
|
Journal of Vector Borne Diseases
|
56
|
2
|
98
|
104
|
9
|
Mehravaran A., Nasab M.R., Mirahmadi H., Sharifi I., Alijani E., Nikpoor A.R., Akhtari J.
|
Protection induced by Leishmania Major antigens and the imiquimod adjuvant encapsulated on liposomes in experimental cutaneous leishmaniasis
|
Infection, Genetics and Evolution
|
70
|
|
27
|
35
|
10
|
Aflatoonian M.R., Sharifi I., Aflatoonian B., Bamorovat M., Heshmatkhah A., Babaei Z., Almani P.G.N., Mohammadi M.A., Salarkia E., Afshar A.A., Sharifi H., Sharifi F., Khosravi A., Khatami M., Arefinia N., Fekri A., Farajzadeh S., Khamesipour A., Mohebali M., Gouya M.M., Shirzadi M.R., Varma R.S.
|
Associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: A cohort study in Iran
|
PLoS Neglected Tropical Diseases
|
13
|
6
|
|
11
|
Bamorovat M., Sharifi I., Aflatoonian M.R., Sadeghi B., Shafiian A., Oliaee R.T., Keyhani A., Afshar A.A., Khosravi A., Mostafavi M., Parizi M.H., Khatami M., Arefinia N.
|
Host's immune response in unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis treated by meglumine antimoniate: A case-control study of Th1 and Th2 pathways
|
International Immunopharmacology
|
69
|
|
321
|
327
|
12
|
Khosravi A., Sharifi I., Tavakkoli H., Keyhani A.R., Afgar A., Salari Z., Bamorovat M., Sharifi F., Khaleghi T., Varma R.S., Dabiri S., Nematollahi-Mahani S.N., Babaee A., Mostafavi M., Hakimi Parizi M., Derakhshanfar A., Salarkia E.
|
Toxico-pathological effects of meglumine antimoniate on human umbilical vein endothelial cells
|
Toxicology in Vitro
|
56
|
|
10
|
18
|
13
|
Bamorovat M., Sharifi I., Fekri A., Keyhani A., Aflatoonian M.R., Heshmatkhah A., Oliaee R.T., Khosravi A., Naderi A., Parizi M.H., Mostafavi M., Varma R.S.
|
A single-group trial of end-stage patients with anthroponotic cutaneous leishmaniasis: Levamisole in combination with Glucantime in field and laboratory models
|
Microbial Pathogenesis
|
128
|
|
162
|
170
|
14
|
Mostafavi M., Khazaeli P., Sharifi I., Farajzadeh S., Sharifi H., Keyhani A., Parizi M.H., Kakooei S.
|
A novel niosomal combination of selenium coupled with glucantime against Leishmania tropica
|
Korean Journal of Parasitology
|
57
|
1
|
1
|
8
|
15
|
Tohidi F., Kazemi B., Bandehpour M., Sharifi I., Rabiei M.R., Saedi Dezaki E., Babaei Z.
|
Transient down-regulation of nucleoside transporter 3 gene expression as a drug target in leishmania major using antisense RNA technology
|
Iranian Journal of Parasitology
|
14
|
1
|
111
|
119
|
16
|
Jafarzadeh A., Nemati M., Sharifi I., Nair A., Shukla D., Chauhan P., Khorramdelazad H., Sarkar A., Saha B.
|
Leishmania species-dependent functional duality of toll-like receptor 2
|
IUBMB Life
|
|
|
|
17
|
Oliaee R.T., Sharifi I., Afgar A., Jafarzadeh A., Kareshk A.T., Bamorovat M., Sharifi H., Babaei Z., Keyhani A., Keyhani A., Abedi L., Sharifi F.
|
Differential expression of TLRs 2, 4, 9, iNOS and TNF-α and arginase activity in peripheral blood monocytes from glucantime unresponsive and responsive patients with anthroponotic cutaneous leishmaniasis caused by Leishmania tropica
|
Microbial Pathogenesis
|
126
|
|
368
|
378
|